Researchers at the University of Pittsburgh Medical Center (UPMC) have developed a genetic test that can help identify pancreatic cancer, even when a patient experiences no obvious symptoms of disease. The details of the PancreaSeq – which uses next-generation sequencing – were published in the journal, Gut.The American Cancer Society estimates that over 53,600 individuals will be diagnosed with pancreatic cancer in 2017 alone. While pancreatic cancer makes up a relatively small percentage of all cancers, it has one of the lowest five-year survival rates of 12 percent for patients diagnosed with early-stage disease. Read more . . .